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Major advances in clinical and lab-
oratory research methods have signifi-
cantly clarified the identification and 
natural course of rheumatic fever in 
the past two decades. The advances in 
methodology include the following: 
Dia gnostic Purity of Population 
The label of rheumatic fever is now 
given to a population of patients more 
distinct and diagnostically "pure" than 
ever before. The Jones criteria, de-
scribed in 1944 and modified in 1956 
(American Heart Association, 1956), 
circumscribe the diagnostic boundaries 
of the disease, and exclude many minor 
illnesses that formerly were designated 
inappropriately as rheumatic fever. 
Other major illnesses that once suc-
cessfully masqueraded as rheumatic 
fever, because they fulfilled the Jones 
criteria, can now be unmasked and 
properly identified by specific labora-
tory tests (such as those used for lupus 
erythematosus, rheumatoid arthritis, 
and sickle cell anemia) and by cardiac 
catheterization (for congenital heart 
disease). These diagnostic purifications 
improve the homogeneity and repro-
ducibility of a population of patients 
with rheumatic fever, thus improving 
the reliability of conclusions drawn 
from observations of the population. 
Spectrum of Post-streptococcal In -
flammation 
The frequent sequential testing of 
multiple streptococcal antibodies (a 
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laboratory technique developed mainly 
in the past two decades) has demon-
strated not only that acute rheumatic 
fever is constantly associated with 
Group A streptococcal infection, but 
also that rheumatic fever is merely an 
arbitrarily defined collection of events 
in the complex clinical spectrum of in-
flammation which can follow strepto-
coccal infection. Within this spectrum, 
the main events used to identify rheu-
matic fever are arthritis, chorea, or 
carditis-occurring alone, in various 
combinations, or concomitantly with 
other clinical features . Because so 
many different combinations of events 
can receive a diagnosis of rheumatic 
fever, the clinical manifestations of the 
disease demonstrate many apparently 
disparate patterns. The differences in 
these clinical patterns (Massell, Fyler, 
and Roy, 1958; Feinstein and Spag-
nuolo, 1962) were responsible for 
much of the past confusion in assess-
ing etiology, pathogenesis, and prog-
nosis. Some of the unclear issues re-
cently resolved are noted below: 
Isolated Chorea 
The latent interval after a strepto-
coccal infection is usually much longer 
for Sydenham's chorea than for other 
"rheumatic" manifestations. Chorea 
may therefore often appear as, or 
after, other types of clinical rheumatic 
inflammation subside. Or it may occur 
alone, i.e., as "pure" chorea, long after 
the streptococcal antibody titers have 
receded to a level too low to permit 
detection of the antecedent infection. 
Asymptomatic Carditis 
Carditis, another type of inflamma-
tion that can occur in the post-strep-
tococcal spectrum, is ordinarily 
asymptomatic if unaccompanied by 
significant fever or by congestive heart 
failure . When carditis occurs alone 
without symptoms created by arthritis, 
chorea, fever, or cardiac complica-
tions, the carditis will not be examined 
while it is acute because the patient 
will not seek medical attention; car-
ditis can thus produce its valvular 
scars silently. When the scars are dis-
covered many years later, rheumatic 
heart disease is said to have occurred 
without a "history of rheumatic 
fever." This type of rheumatic heart 
disease is undetected clinically and de-
velops insidiously only because the 
patient is not examined during the 
acute phase of the carditis. Had the 
patient been symptomatic enough to 
seek medical attention, the signs of 
carditis could have been found. The 
failure of clinicians to find such pa-
tients early is thus a fault neither 
of clinicians nor patients; it is attrib-
utable to the natural behavior of the 
disease. When post-streptococcal in-
flammation produces acute carditis 
asymptomatically, it is clinically un-
examined and hence undetected. 
Severity of Symptoms and Promptness 
of Therapy 
Although pathologists, from exami-
nation of tissue, have long known that 
rheumatic fever "licks at the joints 
and bites at the heart," the clinical 
validity of this maxim, and of its con-
verse has only recently been demon-
strated (Feinstein and Spagnuolo, 
1962). The patterns of clinical be-
havior in rheumatic fever show that 
patients with severe arthritis are quite 
commonly free of carditis, and those 
with carditis severe enough to produce 
congestive heart failure often have no 
joint symptoms. This inverse relation-
ship between the clinical severity of 
arthritis and carditis is a feature of 
natural history that creates a thera-
peutic paradox in the disease. The 
main reason that residual rheumatic 
heart disease occurs less often in pa-
tients treated soon after onset of 
symptoms than it does in those treated 
late is that most patients who seek 
treatment early usually do so because 
of arthritis. They have little or no car-
ditis to begin with. Conversely, the 
late-treatment group consists predomi-
nantly of patients whose solitary car-
ditis took a long time to produce 
symptoms severe enough to make the 
patients seek medical aid. In such pa-
tients, the cardiac damage when first 
found is usually too great for cure by 
anti-inflammatory therapy (Feinstein, 
Stern, and Spagnuolo, 1964b). The 
natural behavior of the illness, rather 
than the treatment, is thus responsible 
for many of the successes in which no 
heart disease is found after early ther-
apy. 
Clinical Identification of Carditis 
The assessment of the noises and 
shadows used as evidence of carditis 
has markedly improved in the past two 
decades by recognition and removal of 
several older diagnostic impediments: 
Reliability of the Examiner 
The reliability of the clinical ex-
aminer who observes and appraises the 
audio-visual evidence of cardiac status 
has been greatly improved by use of 
objective, "blind," examining tech-
niques, multiple examiners, precise de-
scriptions, and rigorous criteria for in-
terpretation. These improvements in 
the scientific performance of the clini-
cian have been aided, and sometimes 
evoked, by modern methods of roent-
genography and phonocardiography. 
As a result of these clinical and tech-
nical improvements, better methods 
and criteria (Feinstein et al., 1964a 
and c) have evolved for avoiding two 
types of observational error (described 
in the next section) that formerly 
created confusion in identifying the 
status of patients, evaluating the re-
sults of therapy, and understanding the 
pathogenesis of rheumatic valvular 
disease. 
Observational Errors and their Conse-
quences 
Errors can be expected during clini-
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cal examination of the heart. Errors 
of commission, in which physiologic 
phenomena are mistakenly regarded 
as pathologic, often arise in making 
the diagnostic distinctions between: 
physiologic systolic murmurs loudly 
audible at the apex and those of mitral 
regurgitation; long physiologic third 
heart sounds and diastolic murmurs; 
split first sounds and presystolic mur-
murs; artifactual curvature of the bar-
ium esophagram and left atrial en-
largement; physiologic variations in 
the roentgenographic cardiac silhou-
ette and those due to cardiomegaly. 
As a result of such errors of commis-
sion made during an acute rheumatic 
attack, "carditis" initially would be di-
agnosed falsely and its "cure"-when 
the true physiologic state was eventu-
ally recognized-would later be attrib-
uted inappropriately to therapy. At a 
subsequent examination of a patient 
previously (and correctly) deemed free 
of carditis during the acute attack, 
such errors would lead to the spurious 
belief that rheumatic heart disease had 
developed insidiously. 
An error of omission occurs when 
a pathologic phenomenon is unde-
tected, or mistakenly regarded as 
physiologic. Such errors commonly 
arise from failure to recognize an 
aortic diastolic or apical presystolic 
murmur when it is present, particu-
larly in situations where suspicion of 
the murmur is not aroused by con-
comitant hemodynamic or roentgeno-
graphic abnormalities. If the abnormal 
murmur persisted and eventually were 
identified correctly, rheumatic heart 
disease would be said to have devel-
oped insidiously in a patient believed 
to be free of it. 
The improved modern auscultatory 
procedures described earlier have re-
duced the incidence of both types of 
error, and accordingly, have reduced 
the number of patients considered to 
have developed rheumatic heart dis-
ease insidiously. Recent data (Fein-
stein et al., 1964a, b, and c; American 
Heart Association, 1960) have shown 
that insidious rheumatic heart disease 
develops de novo primarily in patients 
who were asymptomatic and unex-
amined while they had acute carditis, 
and not in those examined during ar-
thritis or chorea and found free of 
valvular involvement. 
Clarification of Ancillary Tests for 
Carditis 
Holding the belief that many non-
carditic patients might later develop 
insidious rheumatic heart disease, 
clinicians had avidly searched for 
diagnostic aids to find evidence of the 
carditis that appeared to be clinically 
undetectable. Chief among these aids 
were the electrocardiogram and sev-
eral laboratory tests. Although the 
original search for these indices of un-
detectable "subclinical" carditis was 
based on a premise that was itself not 
valid, the lack of validity in the exist-
ing ECG and laboratory tests for car-
ditis has been demonstrated independ-
ently. Prolongation of the P-R interval, 
once regarded as a manifestation of 
carditis, occurs in about one-third of 
patients with post-streptococcal in-
flammation, regardless of concomitant 
clinical evidence of acute carditis. 
Moreover, in careful long-term stud-
ies (Feinstein et al., 1964a, b, and c; 
American Heart Association, 1960), 
acute P-R prolongation has been 
shown to have no prognostic signifi-
cance. Alteration of the QT, interval, 
an observation whose value was never 
proved initially, has now been aban-
doned as an index of acute rheumatic 
carditis. Changes in electrocardio-
graphic T waves of young patients-
particularly in III, in aVF, and in the 
transitional precordial V leads-were 
once regarded as evidence of carditis, 
but are now interpreted with skepti-
cism. Because of normal variations in 
the anatomic position of the heart 
during respiration and with different 
phases of the cardiac cycle, and be-
cause of inconsistent placement of the 
external probing electrode, T-waves 
can vary greatly from one to another 
of the repeated ECG's taken in chil-
dren and adolescents during a rheu-
matic episode. Of the various labora-
tory tests popularized in the past 10 
years, none-despite a transient, later 
discredited, enthusiasm for transami-
nase-has convincingly been demon-
strated to be a specific, reliable index 
of carditis. Consequently, cardiac 
noises and roentgenographic shadows 
remain the major variables that indi-
cate carditis clinically, and the physi-
cian remains the major apparatus for 
assessing these variables. 
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Clinical Course of Acute Rheumatic 
Fever 
For reasons already cited, no single 
clinical pattern can . be properly rep-
resentative of all the ways in which 
rheumatic fever can appear and 
evolve. The patterns are composed, 
however, of individual clinical mani-
festations that often do have typical 
courses. Untreated rheumatic arthritis 
generally lasts no more than several 
weeks, sometimes no more than a few 
days, and leaves no residual defects. 
The knees and ankles are affected most 
commonly; elbows, wrists, and hips 
are involved less often. Although small 
joints of the hands and feet, and the 
vertebral or temporo-mandibular joints 
may be affected uncommonly in rheu-
matic fever, an alternate arthropathic 
condition should always be considered 
and ruled out when these joints are 
involved. The arthritis of rheumatic 
fever often can involve only one joint, 
or several joints simultaneously. The 
development of migratory and poly-
articular arthritis, polyarticular ar-
thritis alone, often depends upon the 
severity of the attack, and the prompt-
ness with which bed rest or anti-in-
flammatory treatment is begun. 
Like arthritis, Sydenham's chorea 
also leaves no permanent defects, al-
though the young patient may develop 
many psychologic scars from scholas-
tic deprivation and from anxieties that 
the peculiar movements of the chorea 
may induce in him or in the people 
who deal with him. The duration and 
severity of chorea vary unpredictably 
in each patient, making an effective 
evaluation of therapy difficult. Some 
attacks last only a few weeks, while 
others last three or four months. The 
movements are rarely so severe as to 
threaten the patient's safety, and often 
they do not impair ambulation; most 
commonly the patient is able to walk 
but cannot write, dress, or feed him-
self. Erythema marginatum seldom 
lasts more than one or two days-
sometimes only a few hours-and, like 
chorea, it often occurs late in a rheu-
matic attack. It can sometimes occur 
early, however, but rarely alone. Sub-
cutaneous nodules are seen much less 
frequently today than in the past (the 
reasons for the change are unknown) 
and almost never occur alone without 
some other rheumatic manifestation. 
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The nodules most commonly are asso-
ciated with carditis, and often with se-
vere carditis. 
If carditis occurs in a particular at-
tack, the evidence is usually present 
when the acutely ill patient is first en-
countered in the hospital (Massell et 
al., 1958; Feinstein and Spagnuolo, 
1962). After hospitalization, a patient 
admitted with significant murmurs 
may develop additional new murmurs, 
rubs, changes in heart size, or conges-
tive heart failure, but significant mur-
murs will seldom appear if none were 
present during the first two weeks of 
observation. In the most common sit-
uation, the patient's carditic manifes-
tations are at their worst when he is 
hospitalized, and they then persist or 
subside during the ensuing acute 
course of the illness. 
The belief that acute rheumatic 
fever was often a "polycyclic" illness 
has also been revised in recent years. 
If untreated, an episode of rheumatic 
fever usually follows a course of 
gradually declining inflammation, in 
which laboratory abnormalities last 
longer than clinical ones, except for 
chorea. The sedimentation rate reaches 
normal levels in an average of three 
months for patients without carditis, 
and in four months for those with car-
ditis. Once a rheumatic attack has be-
gun, anti-inflammatory treatment can 
suppress some of the manifestations of 
the inflammation, but the treatment 
does not repair the damage done to 
the heart. The attack may be followed 
by rebounds that represent an outlet 
for the inflammatory stimulus that re-
mained dormant during the preceding 
suppression of inflammation (Feinstein 
and Spagnuolo, 1961). Post-therapeu-
tic rebounds are one of three mecha-
nisms by which acute rheumatic in-
flammation can recrudesce. A second 
mechanism is a recurrence of acute 
rheumatic fever, provoked by a new 
streptococcal infection. A third mech-
anism, still poorly understood, is pres-
ent in about 5% of patients with rheu-
matic fever. In these patients, the 
acute attack is excessively prolonged 
or "chronic," with clinical and labora-
tory evidence of acute inflammation 
present for more than eight months in 
the absence of an intervening strepto-
coccal infection. Unlike post-thera-
peutic rebounds, the exacerbations of 
inflammation in these "chronic" at-
tacks show no temporal relationship 
to preceding suppressive treatment. 
"Chronic" attacks are most likely to 
occur in patients with severe cardiac 
damage and in those who have had 
many previous episodes of rheumatic 
fever (Taranta, Spagnuolo, and Fein-
stein, 1962). 
Long Term Sequelae of Rheumatic 
Fever 
Great improvements have been pro-
duced in the past two decades in epi-
demiologic methods for careful long-
term observation of patient populations 
having identified attacks of rheumatic 
fever. Several recent large-scale studies 
(Feinstein et al., 1964a, b, and c; 
American Heart Association, 1960) 
of rheumatic sequelae have been per-
formed by cooperative efforts of differ-
ent groups of investigators or by 
single institutions, and have shown the 
following results: 
(a) Patients initially free of clinical 
evidence of carditis remain essentially 
free of it thereafter. Rheumatic heart 
disease remains in about 9% of pa-
tients with equivocal initial evidence 
of carditis. 
(b) In patients with congestive heart 
failure or marked cardiomegaly in the 
acute attack, evidence of cardiac dam-
age seldom disappears. Patients with 
such severe carditis are the usual 
source of those who die at an early 
age. If they survive the acute rheu-
matic episode, the patients with severe 
acute carditis often die later as a re-
sult of the remaining cardiac damage, 
and not necessarily because of per-
sistent or recurrent active rheumatic 
inflammation. 
(c) Significant murmurs later dis-
appear in about 40% of patients who 
had murmurs but no cardiomegaly or 
decompensation during a rheumatic 
attack. The disappearance of murmurs 
is most likely to occur in patients with 
systolic rather than diastolic murmurs, 
with murmurs of one valve rather than 
two, and with no previous episodes of 
rheumatic fever. 
(d) Except for a small percentage of 
patients incapacitated by cardiac symp-
toms, most rheumatic patients have no 
clinical impairment of cardiac func-
tion during adolescence, even though 
signs of major cardiac damage may be 
present. Restriction of scholastic or 
physical activities in such asympto-
matic patients appears to have no 
medical benefits and may create ad-
verse psychosocial reactions (Fein-
stein et al., 1962). 
( e) Recurrences of rheumatic fever 
may make cardiac damage worse in 
patients who already have it, but do 
not generally bring valvular damage 
to patients previously free of it. In 
patients without previous valvular 
damage, a recurrence is often mani-
fested by arthritis, chorea, or occa-
sionally pericarditis, but seldom by 
persistent new valvular murmurs. 
Treatment of Acute Rheumatic Fever 
Although the many studies of ther-
apy of acute rheumatic fever per-
formed in the past decade have helped 
clarify the course of the disease, they 
have not reached uniform or consist-
ent agreement about the value of 
steroid treatment. The main difficulty 
has been the absence of reproducibil-
ity in the different methods used to 
allocate patients initially into com-
parable sub-groups of the rheumatic 
spectrum, and to identify the presence 
and disappearance of carditis (Fein-
stein, 1961). At present, steroids have 
not been proved superior to salicylates 
in the routine treatment of rheumatic 
fever, nor has either of these agents 
been proved consistently more effec-
tive than no treatment. Patients with-
out carditis usually emerge free of 
heart disease, and those with severe 
carditis usually have residual heart 
disease, regardless of the mode of 
treatment. The comparison of thera-
peutic agents is thus best restricted to 
patients with "mild" carditis, i.e., mur-
murs only. In such patients, current 
therapeutic results are inconclusive 
because of lack of uniformity in the 
identification of murmurs by different 
investigators. 
Despite the many therapeutic con-
troversies, certain approaches are ac-
cepted almost unanimously: 
(a) A course of antimicrobial agents 
adequate to eradicate streptococci 
should be given when the diagnosis of 
acute rheumatic fever is established, 
even though throat culture and ASO 
titer are normal. Massive doses of anti-
biotics for long periods of time have 
not been proved more effective for 
therapy of rheumatic fever than an 
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ordinary streptococcal-eradicating reg-
imen. 
(b) Patients without clinical evi-
dence of carditis can be made com-
fortable by salicylates or analgesics, 
and do not require steroids. 
(c) Chorea is a yet unsolved thera-
peutic enigma, with no consistent suc-
cess obtained by any of the various 
sedatives, tranquillizers, and anti-in-
flammatory agents that have been 
tested. 
(d) Steroids are unequivocally better 
than salicylates in a small percentage 
of rheumatic patients who have over-
whelming decompensated carditis, and 
whose inflammation can not be con-
trolled with salicylates. In these situa-
tions, the steroids do not seem to re-
pair any of the damage left by the 
rheumatic fire, but save the heart from 
immediate acute destruction by the 
fire, even though the severe residual 
damage may lead to death a few years 
later. 
(e) In ordinary mild carditis, ster-
oids have no unequivocally demon-
strable superiority to salicylates. The 
main advantage of steroids is a more 
rapid clinical and laboratory disap-
pearance of certain non-cardiac in-
flammatory abnormalities; the main 
disadvantage of steroids is the fre-
quent development of cutaneous striae 
(in young patients) during treatment 
and the common occurrence of re-
bounds after treatment. The rebound 
phenomenon after steroids can often 
be eliminated or minimized by giving 
salicylates as overlap treatment, start-
ing on the date of reduction in steroid 
dosage and continuing for at least 
several weeks after steroids are 
stopped. 
These clarifications in our knowl-
edge of natural history of rheumatic 
fever have come from better under-
standing of properties of the strepto-
coccus and of the clinical reactions it 
elicits in its human host. The next two 
decades of research should help to 
clarify the reasons and mechanisms 
for susceptibility of the host. 
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